Windlas Biotech Ltd
NSE:WINDLAS

Watchlist Manager
Windlas Biotech Ltd Logo
Windlas Biotech Ltd
NSE:WINDLAS
Watchlist
Price: 1 116 INR 9.83%
Market Cap: 23.2B INR
Have any thoughts about
Windlas Biotech Ltd?
Write Note

Intrinsic Value

The intrinsic value of one WINDLAS stock under the Base Case scenario is 485.51 INR. Compared to the current market price of 1 116 INR, Windlas Biotech Ltd is Overvalued by 56%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

WINDLAS Intrinsic Value
485.51 INR
Overvaluation 56%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Windlas Biotech Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for WINDLAS cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about WINDLAS?
Bearish
Neutral
Bullish
Discover Undervalued Stocks
Life Sciences Tools & Services Industry

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Windlas Biotech Ltd

Provide an overview of the primary business activities
of Windlas Biotech Ltd.

What unique competitive advantages
does Windlas Biotech Ltd hold over its rivals?

What risks and challenges
does Windlas Biotech Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Windlas Biotech Ltd.

Provide P/S
for Windlas Biotech Ltd.

Provide P/E
for Windlas Biotech Ltd.

Provide P/OCF
for Windlas Biotech Ltd.

Provide P/FCFE
for Windlas Biotech Ltd.

Provide P/B
for Windlas Biotech Ltd.

Provide EV/S
for Windlas Biotech Ltd.

Provide EV/GP
for Windlas Biotech Ltd.

Provide EV/EBITDA
for Windlas Biotech Ltd.

Provide EV/EBIT
for Windlas Biotech Ltd.

Provide EV/OCF
for Windlas Biotech Ltd.

Provide EV/FCFF
for Windlas Biotech Ltd.

Provide EV/IC
for Windlas Biotech Ltd.

Compare the intrinsic valuations
of Windlas Biotech Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Windlas Biotech Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Windlas Biotech Ltd compared to its peers.

Compare the P/E ratios
of Windlas Biotech Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Windlas Biotech Ltd with its peers.

Analyze the financial leverage
of Windlas Biotech Ltd compared to its main competitors.

Show all profitability ratios
for Windlas Biotech Ltd.

Provide ROE
for Windlas Biotech Ltd.

Provide ROA
for Windlas Biotech Ltd.

Provide ROIC
for Windlas Biotech Ltd.

Provide ROCE
for Windlas Biotech Ltd.

Provide Gross Margin
for Windlas Biotech Ltd.

Provide Operating Margin
for Windlas Biotech Ltd.

Provide Net Margin
for Windlas Biotech Ltd.

Provide FCF Margin
for Windlas Biotech Ltd.

Show all solvency ratios
for Windlas Biotech Ltd.

Provide D/E Ratio
for Windlas Biotech Ltd.

Provide D/A Ratio
for Windlas Biotech Ltd.

Provide Interest Coverage Ratio
for Windlas Biotech Ltd.

Provide Altman Z-Score Ratio
for Windlas Biotech Ltd.

Provide Quick Ratio
for Windlas Biotech Ltd.

Provide Current Ratio
for Windlas Biotech Ltd.

Provide Cash Ratio
for Windlas Biotech Ltd.

What is the historical Revenue growth
over the last 5 years for Windlas Biotech Ltd?

What is the historical Net Income growth
over the last 5 years for Windlas Biotech Ltd?

What is the current Free Cash Flow
of Windlas Biotech Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Windlas Biotech Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Windlas Biotech Ltd

Current Assets 4.3B
Cash & Short-Term Investments 2.1B
Receivables 1.4B
Other Current Assets 884.1m
Non-Current Assets 1.9B
Long-Term Investments 43.2m
PP&E 1.8B
Intangibles 44.7m
Other Non-Current Assets 58.4m
Current Liabilities 1.7B
Accounts Payable 1.3B
Other Current Liabilities 402.4m
Non-Current Liabilities 45.2m
Long-Term Debt 20.2m
Other Non-Current Liabilities 25m
Efficiency

Earnings Waterfall
Windlas Biotech Ltd

Revenue
6.6B INR
Cost of Revenue
-4.1B INR
Gross Profit
2.5B INR
Operating Expenses
-1.8B INR
Operating Income
654.4m INR
Other Expenses
-58.4m INR
Net Income
596m INR

Free Cash Flow Analysis
Windlas Biotech Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

WINDLAS Profitability Score
Profitability Due Diligence

Windlas Biotech Ltd's profitability score is 55/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Year Average ROIC
ROE is Increasing
ROIC is Increasing
55/100
Profitability
Score

Windlas Biotech Ltd's profitability score is 55/100. The higher the profitability score, the more profitable the company is.

WINDLAS Solvency Score
Solvency Due Diligence

Windlas Biotech Ltd's solvency score is 95/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Negative Net Debt
Low D/E
95/100
Solvency
Score

Windlas Biotech Ltd's solvency score is 95/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

WINDLAS Price Targets Summary
Windlas Biotech Ltd

There are no price targets for WINDLAS.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for WINDLAS?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for WINDLAS is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Windlas Biotech Ltd Logo
Windlas Biotech Ltd

Country

India

Industry

Life Sciences Tools & Services

Market Cap

23.2B INR

Dividend Yield

0.49%

Description

Windlas Biotech Ltd. operates as a contract development and manufacturing organization (CDMO). The firm provides a range of contract development and manufacturing organization (CDMO) services ranging from product discovery, product development, licensing and commercial manufacturing of generic products, including complex generics. Its therapeutic categories, such as, anti-diabetic, cardiovascular, neuropsychiatry and respiratory therapies. The Company’s service capabilities include formulation development, technology scale-up and full-scale commercial manufacturing. The company has capabilities for both solid and liquid pharmaceutical dosage forms. The Company’s market its own manufactured nutraceutical, pharmaceutical and ayurvedic products to serve the semi-urban and rural communities. The company also has a salesforce and distribution network spread across over 14 states. The Company’s manufacturing facilities are located at Dehradun in Uttarakhand.

Contact

40/1 Mohabewala Industrial Area
windlas.com

IPO

2021-08-16

Employees

-

Officers

CFO & CEO
Ms. Komal Gupta
Company Secretary & Compliance Officer
Mr. Ananta Narayan Panda
Whole-Time Director
Mr. Ashok Kumar Windlass
MD & Executive Director
Mr. Hitesh Windlass
Joint MD & Executive Director
Mr. Manoj Kumar Windlass
Executive Director
Mr. Pawan Kumar Sharma
Show More
President of Sales & Marketing
Mr. Mohammed Aslam
Site Quality Head
Mr. Om Prakash Sule
Show Less

See Also

Discover More
What is the Intrinsic Value of one WINDLAS stock?

The intrinsic value of one WINDLAS stock under the Base Case scenario is 485.51 INR.

Is WINDLAS stock undervalued or overvalued?

Compared to the current market price of 1 116 INR, Windlas Biotech Ltd is Overvalued by 56%.

Back to Top